Handelsavisen
prelaunch
Companies Healthcare SEYKM.IS
SE
SEYKM.IS Borsa Istanbul Medical Equipment, Supplies & Distribution

Seykm.Is

$5,44
Open in Charts → Attach watcher ⌖
TRY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,1B TRY
P/E
EV / Rev
Div yield
0,00 %
Op margin
-9,3 %
ROE
-8,0 %
Net margin
-16,3 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

SEYKM.IS operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Business. SEYKM.IS operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-8,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning SEYKM.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to SEYKM.IS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    SEYKM.IS operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a high proportion of equity, with total equity of 495,021,010 TRY and total liabilities of 86,599,260 TRY, resulting in a debt-to-equity ratio of 0.0. The liquidity position is marked by a current ratio of 7.76, indicating strong short-term liquidity. However, the company has a negative net cash position after subtracting total debt, which is a key liquidity flag.

    Profitability metrics show a challenging performance, with a return on equity of -7.97% and a return on assets of -6.79%. The company reported a net loss of 39,473,160 TRY and an operating loss of 22,576,860 TRY. These figures are below the industry median for profitability, indicating a need for operational improvements to align with industry standards.

    The company's revenue is concentrated in a single segment, as disclosed in its financials, with no specific geographic breakdown provided. This lack of diversification may pose a risk if the primary market experiences downturns. The absence of detailed segment and geographic data limits the ability to assess exposure to different markets.

    The company's growth trajectory is uncertain, with no specific revenue growth projections provided. Historical data shows a decline in operating and net income, suggesting potential challenges in maintaining or increasing revenue. The absence of clear growth indicators makes it difficult to assess future performance.

    Risk factors include a medium liquidity risk due to the negative net cash position and the absence of long-term debt. The dilution risk is low, as there is no difference between basic and diluted shares outstanding. However, the company's financial performance, including negative operating and net income, may necessitate future financing, which could lead to dilution.

    Recent events and filings do not provide specific details on strategic initiatives or operational changes. The company's financial statements highlight the need for cost management and operational efficiency to improve profitability. No recent significant events or transcripts are available to provide further insight into the company's strategic direction.

    Key takeaways
    • The company has a strong equity position but faces liquidity challenges due to a negative net cash position.
    • Profitability metrics are negative, indicating a need for operational improvements to align with industry standards.
    • The company's revenue is concentrated in a single segment, posing a risk if the primary market experiences downturns.
    • Growth projections are unclear, and historical data shows a decline in operating and net income.
    • The company's financial performance may necessitate future financing, which could lead to dilution.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $5,44
    Market cap
    $1.11B
    Enterprise value
    $1.11B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    2.2x
    P / Tangible book
    2.2x
    Tangible book
    $495.0M
    Net cash
    -$115.0k
    Current ratio
    7.8
    Debt / equity
    0.0
    ROA
    -6.8%
    ROE
    -8.0%
    Cash conversion
    83.0%
    CapEx / revenue
    -5.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-9,3 %Below median
    Net Margin-16,3 %Below median
    ROE-8,0 %Bottom quartile
    Capex / Rev-5,1 %Above median
    D/E0,00Above P75
    Cash Conv0,83Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • SEYKM.IS Market data — financials · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    SEYKM.ISCanonical
    Borsa Istanbul · TRY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage